| Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system SA Stanley, S Raghavan, WW Hwang, JS Cox Proceedings of the National Academy of Sciences 100 (22), 13001-13006, 2003 | 712 | 2003 |
| The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis SA Stanley, JE Johndrow, P Manzanillo, JS Cox The Journal of Immunology 178 (5), 3143-3152, 2007 | 496 | 2007 |
| Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening SA Stanley, SS Grant, T Kawate, N Iwase, M Shimizu, C Wivagg, M Silvis, ... ACS chemical biology 7 (8), 1377-1384, 2012 | 298 | 2012 |
| Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth SA Stanley, AK Barczak, MR Silvis, SS Luo, K Sogi, M Vokes, MA Bray, ... PLoS pathogens 10 (2), e1003946, 2014 | 271 | 2014 |
| C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis PADG Champion, SA Stanley, MM Champion, EJ Brown, JS Cox Science 313 (5793), 1632-1636, 2006 | 268 | 2006 |
| A non‐RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis JA MacGurn, S Raghavan, SA Stanley, JS Cox Molecular microbiology 57 (6), 1653-1663, 2005 | 236 | 2005 |
| HIF-1α is an essential mediator of IFN-γ–dependent immunity to Mycobacterium tuberculosis J Braverman, KM Sogi, D Benjamin, DK Nomura, SA Stanley The Journal of Immunology 197 (4), 1287-1297, 2016 | 216 | 2016 |
| Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense M Knight, J Braverman, K Asfaha, K Gronert, S Stanley PLoS pathogens 14 (1), e1006874, 2018 | 187 | 2018 |
| Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1α and repression of NF-κB J Braverman, SA Stanley The Journal of Immunology 199 (5), 1805-1816, 2017 | 135 | 2017 |
| Host–Pathogen Interactions During Mycobacterium tuberculosis infections SA Stanley, JS Cox Pathogenesis of Mycobacterium tuberculosis and its interaction with the host …, 2013 | 131 | 2013 |
| RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities AK Barczak, JE Gomez, BB Kaufmann, ER Hinson, L Cosimi, ... Proceedings of the national academy of sciences 109 (16), 6217-6222, 2012 | 124 | 2012 |
| Stereocontrol in intermolecular dirhodium (II)-catalyzed carbonyl ylide formation and reactions. Dioxolanes and dihydrofurans MP Doyle, DC Forbes, MN Protopopova, SA Stanley, MM Vasbinder, ... The Journal of Organic Chemistry 62 (21), 7210-7215, 1997 | 121 | 1997 |
| T cell-intrinsic requirement for NF-κB induction in postdifferentiation IFN-γ production and clonal expansion in a Th1 response RA Corn, MA Aronica, F Zhang, Y Tong, SA Stanley, SRA Kim, ... The Journal of Immunology 171 (4), 1816-1824, 2003 | 114 | 2003 |
| SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA A Jack, LS Ferro, MJ Trnka, E Wehri, A Nadgir, X Nguyenla, D Fox, ... PLoS biology 19 (10), e3001425, 2021 | 108 | 2021 |
| Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32 SA Stanley, T Kawate, N Iwase, M Shimizu, AE Clatworthy, ... Proceedings of the National Academy of Sciences 110 (28), 11565-11570, 2013 | 108 | 2013 |
| STING-activating adjuvants elicit a Th17 immune response and protect against Mycobacterium tuberculosis infection E Van Dis, KM Sogi, CS Rae, KE Sivick, NH Surh, ML Leong, DB Kanne, ... Cell reports 23 (5), 1435-1447, 2018 | 106 | 2018 |
| Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model SS Grant, T Kawate, PP Nag, MR Silvis, K Gordon, SA Stanley, ... ACS chemical biology 8 (10), 2224-2234, 2013 | 86 | 2013 |
| The Innate Immune Response to Mycobacterium tuberculosis Infection MM Ravesloot-Chávez, E Van Dis, SA Stanley Annual review of immunology 39, 611-637, 2021 | 81 | 2021 |
| Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32 T Kawate, N Iwase, M Shimizu, SA Stanley, S Wellington, E Kazyanskaya, ... Bioorganic & medicinal chemistry letters 23 (22), 6052-6059, 2013 | 81 | 2013 |
| Enantiocontrolled macrocycle formation by catalytic intramolecular cyclopropanation MP Doyle, W Hu, B Chapman, AB Marnett, CS Peterson, JP Vitale, ... Journal of the American Chemical Society 122 (24), 5718-5728, 2000 | 80 | 2000 |
